Literature DB >> 21899915

Complement polymorphisms: geographical distribution and relevance to disease.

L Ermini1, I J Wilson, T H J Goodship, N S Sheerin.   

Abstract

The evolution of man has been characterised by recurrent episodes of migration and settlement with infectious disease a constant threat. This long history of demographic change, together with the action of evolutionary forces such as natural selection and genetic drift, has shaped human genetic diversity. In particular, the interaction between humans, pathogens and the environment has played a crucial role in generating patterns of human genetic variation. The complement system plays a crucial role in the early protective immune response after exposure to a pathogen. Pathogens, over time, have developed mechanisms to circumvent the effects of complement which in turn has led to development of a more complex complement system. During the evolution of the complement system genes coding complement proteins have evolved polymorphisms, some of which have a functional effect, and this may reflect human-pathogen interaction and geographical origin. An example is the polymorphism Ile62Val (rs800292 (A>G)) in the complement regulator Factor H gene which alters the susceptibility to age-related macular degeneration (AMD), with the Ile62 polymorphism protecting against AMD. When sub-Saharan African and European populations are compared, the frequency of this polymorphism shows a very marked geographical distribution. Polymorphisms in other complement genes such as complement factor B show similar trends. This paper describes the geographical variation present in complement genes and discusses the implications of these observations. The analysis of genetic variation in complement genes is a promising tool to unravel mechanisms of host-pathogen interaction and can provide new insights into the evolution of the human immune system.
Copyright © 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21899915     DOI: 10.1016/j.imbio.2011.07.020

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  7 in total

1.  Human genetic variation altering anthrax toxin sensitivity.

Authors:  Mikhail Martchenko; Sophie I Candille; Hua Tang; Stanley N Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

2.  The investigation of allele and genotype frequencies of human C3 (rs2230199) in south Iranian population.

Authors:  Najmeh Bazyar; Negar Azarpira; Saied Reza Khatami; Hamid Galehdari
Journal:  Mol Biol Rep       Date:  2012-06-21       Impact factor: 2.316

Review 3.  The peopling of the African continent and the diaspora into the new world.

Authors:  Michael C Campbell; Jibril B Hirbo; Jeffrey P Townsend; Sarah A Tishkoff
Journal:  Curr Opin Genet Dev       Date:  2014-12       Impact factor: 5.578

Review 4.  The complotype: dictating risk for inflammation and infection.

Authors:  Claire L Harris; Meike Heurich; Santiago Rodriguez de Cordoba; B Paul Morgan
Journal:  Trends Immunol       Date:  2012-06-29       Impact factor: 16.687

5.  Quantitative multiplex profiling of the complement system to diagnose complement-mediated diseases.

Authors:  Esther Willems; Laura Lorés-Motta; Andrea Zanichelli; Chiara Suffritti; Michiel van der Flier; Renate G van der Molen; Jeroen D Langereis; Joris van Drongelen; Lambert P van den Heuvel; Elena Volokhina; Nicole Caj van de Kar; Jenneke Keizer-Garritsen; Michael Levin; Jethro A Herberg; Federico Martinon-Torres; Hans Jtc Wessels; Anita de Breuk; Sascha Fauser; Carel B Hoyng; Anneke I den Hollander; Ronald de Groot; Alain J van Gool; Jolein Gloerich; Marien I de Jonge
Journal:  Clin Transl Immunology       Date:  2020-12-09

6.  Determining the population frequency of the CFHR3/CFHR1 deletion at 1q32.

Authors:  Lucy V Holmes; Lisa Strain; Scott J Staniforth; Iain Moore; Kevin Marchbank; David Kavanagh; Judith A Goodship; Heather J Cordell; Timothy H J Goodship
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

7.  The Plasmodium falciparum blood stages acquire factor H family proteins to evade destruction by human complement.

Authors:  Thiago F A Rosa; Ansgar Flammersfeld; Che J Ngwa; Meike Kiesow; Rainer Fischer; Peter F Zipfel; Christine Skerka; Gabriele Pradel
Journal:  Cell Microbiol       Date:  2015-11-12       Impact factor: 3.715

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.